SNRPE antibody (AA 330-380)
Quick Overview for SNRPE antibody (AA 330-380) (ABIN6991869)
Target
See all SNRPE AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 330-380
-
Specificity
- This antibody will not cross-react with C-raf.
-
Purification
- B-raf Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- Anti-B-raf antibody was raised against a peptide corresponding to 19 amino acids near the center of human B-raf. The immunogen is located within amino acids 330 - 380 of B-raf.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 0.5-2 μ,g/mL, IHC: 2.5 μ,g/mL, IF: 20 μ,g/mL.
Antibody validated: Western Blot in human and mouse samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- B-raf Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- B-raf antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- SNRPE (Small Nuclear Ribonucleoprotein Polypeptide E (SNRPE))
-
Alternative Name
- B-raf
-
Background
- B-raf Antibody: B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt pathways interact with each other to regulate growth and in some cases tumorigenesis. Mutations in B-raf have been associated with several cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung, leading to speculation on the possibility of B-raf as a therapeutic target for treating cancers. Mutations in this gene have also been associated with cardiofaciocutaneous syndrome (CFCS), a disease characterized by heart defects, mental retardation and a distinctive facial appearance.
-
Molecular Weight
-
Predicted: 94kD
Observed: 94 kD kDa -
Gene ID
- 673
-
UniProt
- P15056
-
Pathways
- Ribonucleoprotein Complex Subunit Organization, Hepatitis C
Target
-